Guangdong, China

Junye Tan


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Junye Tan: Innovating Antibody Development in Guangdong

Introduction

Junye Tan, a prominent inventor based in Guangdong, China, has made significant strides in the field of biotechnology. With a focus on developing antibodies, Tan's work has the potential to impact medical treatments and healthcare. His innovative approach has garnered attention within the scientific community, showcasing his dedication to advancing biotechnological solutions.

Latest Patents

Tan holds a patent titled "Development of recombinant chicken IgY monoclonal antibody and scFv antibodies raised against human thymidine kinase 1 expressed in mammalian cells and use thereof." This groundbreaking patent details the creation of a recombinant chicken IgY monoclonal antibody, along with a single-chain variable fragment (scFv) antibody that targets human thymidine kinase 1. The patent emphasizes the preparation method and potential uses of these antibodies, which could play a crucial role in therapeutic applications.

Career Highlights

Currently, Junye Tan is employed at Sino-Swed Tongkang Bio-Tech (Shenzhen) Limited, where he collaborates with a team of dedicated professionals. His innovative work in antibody development reflects his commitment to advancing biotechnology. Tan's passion and expertise are evident through his contributions to the field, positioning him as an influential figure among contemporary inventors.

Collaborations

Throughout his career, Tan has worked alongside notable colleagues, including Zuosheng Li and Hu Chen. Their collaborative efforts foster a productive environment that encourages innovation and the pursuit of new scientific advancements. Together, they contribute to breakthroughs that help drive progress in the biotechnological sector.

Conclusion

In summary, Junye Tan’s dedication to developing advanced antibodies is paving the way for potential breakthroughs in medical science. His patent underscores the significance of recombinant antibodies and their function in targeted therapies. As he continues his work at Sino-Swed Tongkang Bio-Tech, the scientific community eagerly anticipates further innovations from Tan and his collaborators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…